MKI67 and neuroendocrine carcinoma: In 2017, the new WHO grading system for PanNENs introduced a further sub-group: well-differentiated NET with Ki67 > 20% (grade 3 PanNET), distinct from poorly-differentiated neuroendocrine carcinoma (grade 3 PanNEC) (Table 1) [13,14].